Abstract:Vascular, Ahead of Print. ObjectiveTo systematically evaluate the risk factors for developing diabetic foot ulcers (DFU).MethodsThe Cochrane Library, PubMed, Web of Science, SinoMed, CNKI, VIP, and Wanfang Data were searched for relevant studies on DFU risk factors, and the search time frame was from database creation to March 2022. Meta-analysis was performed using RevMan 5.3.ResultsA total of 26 publications were included, including 3 cohort studies, 22 case–control studies, and one cross-sectional study. Meta-analysis showed that advanced age [MD = 6.04, 95% CI (3.92, 8.16)], male [OR = 1.84, 95% CI (1.48, 2.29)], elevated body mass index [MD = 1.58, 95% CI (0.47, 2.69)], prolonged duration of diabetes [MD = 2.72, 95% CI (2.33, 3.11)], comorbid nephropathy [OR = 3.15, 95% CI (2.68, 4.60)], comorbid neuropathy [OR = 4.80, 95% CI (2.79, 8.27)], comorbid retinopathy [OR = 3.37, 95% CI (2.26, 5.02)], elevated systolic blood pressure [OR = 8.19, 95% CI (6.33, 10.05)], elevated fasting glucose [MD = 1.60, 95% CI (0.21, 3.00)], elevated glycated hemoglobin [MD = 1.24, 95% CI (0.94, 1.54)], elevated triglycerides [MD = 0.44 (95% CI (0.15, 0.73)], elevated fibrinogen [MD = 1.35, 95% CI (0.62, 2.08)], elevated white blood cell count [MD = 2.56, 95% CI (2.24, 2.88)], elevated C-reactive protein [MD = 15.08, 95% CI (8.03, 22.13)], decreased ankle-brachial ratio [MD = −0.26, 95% CI (−0.36, −0.16)], and decreased total protein levels [MD = −4.58, 95% CI (−6.91, −2.25)] were risk factors for developing DFU (p < 0.05), and increased HDL cholesterol levels [MD = −0.22, 95% CI (−0.36, −0.08)] were protective factor for developing DFU (p < 0.05).ConclusionThere are many risk factors for developing of ulcers in the diabetic feet, and early prevention and intervention should be performed as early as possible to assess the risk of developing diabetic foot patients.

Growth factors in the pathogenesis of diabetic foot ulcers.

Fibroblast Growth Factor in Diabetic Foot Ulcer: Progress and Therapeutic Prospects

Role of growth factors and cytokines in diabetic foot ulcer healing: A detailed review

Vascular Endothelial Specific Growth Factors and Diabetic Nephropathy

Progress in Medical Therapy for Diabetic Foot Ulcer

Experimental treatments in clinical trials for diabetic foot ulcers: wound healers in the pipeline

Diabetic foot ulcer: Challenges and future

Recent advances in the adjunctive management of diabetic foot ulcer: Focus on noninvasive technologies

Research progress of wound surface repair of diabetic feet by transforming growth factor-β and its receptor

The risk factors in diabetic foot ulcers and predictive value of prognosis of wound tissue vascular endothelium growth factor

Growth factors, as biological macromolecules in bioactivity enhancing of electrospun wound dressings for diabetic wound healing: A review

The pathophysiology of diabetic foot: a narrative review

Physiological and Pathophysiological Aspects of Diabetic Foot Ulcer and its Treatment Strategies

Role of microRNAs in diabetic foot ulcers: Mechanisms and possible interventions

Risk factors for diabetic foot ulcers: A systematic review and meta-analysis

Natural Biologics Accelerate Healing of Diabetic Foot Ulcers by Regulating Oxidative Stress

Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research

Research progress on and molecular mechanism of vacuum sealing drainage in the treatment of diabetic foot ulcers

Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities

Materials and Cytokines in the Healing of Diabetic Foot Ulcers

Stem Cell-Based Therapy for Diabetic Foot Ulcers